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ABSTRACT: Cooperation between pairs of transcription factors 
(TFs) has been widely demonstrated to play a pivotal role in the 
spatiotemporal regulation of gene expression, but blocking coop-
erative TF pair–DNA interactions synergistically has been chal-
lenging. To achieve this, we designed programmable DNA binder 
pyrrole-imidazole polyamides conjugated to host–guest assem-
blies (Pip-HoGu) to mimic the cooperation between natural TF 
pairs. By incorporating cyclodextrin (Cyd)–adamantane (Ada), we 
synthesized Ada1 (PIP1-Ada) and Cyd1 (PIP2-Cyd), which were 
evaluated using Tm, EMSA, competitive, and SPR assays and 
molecular dynamics studies. The results consistently demonstrat-
ed that Pip-HoGu system formed stable noncovalent cooperative 
complexes, thereby meeting key criteria for mimicking a TF pair. 
The system also had a longer recognition sequence (two-PIP bind-
ing length plus gap distance), favorable sequence selectivity, 
higher binding affinity, and in particular, a flexible gap distance 
(0–5 bp). For example, Ada1–Cyd1 showed thermal stability of 
7.2 °C and a minimum free energy of interaction of –2.32 
kcal·mol–1 with a targeting length of 14 bp. Furthermore, cell-
based evaluation validated the capability of Pip-HoGu to exhibit 
potent cooperative inhibitory effects on gene expression under 
physiological conditions by disrupting TF pair–DNA function. In 
conclusion, the modular design of Pip-HoGu defines a general 
framework for mimicking naturally occurring cooperative TF 
pair–DNA interactions that offers a promising strategy for appli-
cations in the precise manipulation of cell fate. 
Manipulating spatiotemporally variable gene expression has 
been the goal of generations of scientists1,2. In mammals, there are 
approximately 1000 transcription factors (TFs) that extensively 
regulate gene expression patterns, and 55–70% of these TFs may 
be functioning as cooperative TF pairs via homo-/heterodimers to 
ensure high binding affinity and extended recognition sequence3,4. 
Programmable molecules, e.g., nucleic acid analogues and pyr-
role-imidazole polyamides (PIPs), can disrupt individual TF–
DNA interactions5-7, but cannot block interactions between col-
laborative TF pairs and DNA. More specifically, the gap sequenc-
es between the two binding motifs of the TF pair are not con-
served and the gap distances are relatively flexible, ranging from 
–1–5 bp8. Most significantly, by switching cooperative partners, 
TF pairs can exert divergent biological functions. For example, 
Sox2/Oct4 instigates pluripotent gene activation, but Oct4/Sox17 
functions as a HEX activator and Sox2/Pax6 plays a pivotal role 
in ocular lens development9,10. Accordingly, disrupting the indi-
vidual binding sites of Sox2 or Oct4, rather than synergistically 
disrupting those of both TFs will result in complex biological 
outcomes. Therefore, novel strategies are needed to address these 
challenges to the implementation of deliberate and precise manip-
ulation of gene expression patterns. 
PIPs are the best characterized programmable DNA minor-
groove binders that can compete with TF binding, with the bind-
ing rules that Py/Im recognizes C/G, Im/Py recognizes G/C, and 
Py/Py recognizes A/T and T/A11. Despite substantial progress, 
there is still a long way to go before these molecules can be ap-
plied clinically7,12. The short recognition sequences of PIPs lead 
to high off-target rates, but the extension of PIP length significant-
ly impairs its cell permeability13,14. Critically, the fixed PIPs-
binding motif (4–8 bp) without elasticity, is unsuitable for block-






































































































































Figure 1. Overview of cooperative interactions of a TF pair tar-
geting a sequence associated with two components of Pip-HoGu 
assembly, Ada1 and Cyd1. n = gap distance. (Bottom) Chemical 
structures of Ada1, Ada2, and Cyd1. 
In this context, we envisaged the integration of PIPs with a co-
operative system to mimic the homo- or heterodimer binding sys-
tems of TF pairs. There are several classic noncovalent coopera-
tive systems, including nucleic acid analogues, metal ion–ligand, 
and host–guest systems (e.g., cyclodextrin (Cyd), cucurbit[n]uril, 
and carcerands with guests)16-21. Among these cooperative sys-
tems, Cyd–adamantane (Ada) has been extensively studied as an 
exemplary host–guest system both in vitro and in cells22,23. By 
replacing a leucine-zipper dimerization domain with Cyd/Ada, 
Morii and colleagues designed an artificial system in which the 
cooperative Cyd–Ada interaction highly stabilized the interaction 
 of DNA with the DNA-binding domains of GCN4 homodimer24,25. 
The work of Mascarenas and colleagues of Cyd–Ada assisted 
DNA-binding peptide–distamycin derivatives represented a step 
forward in the development of smaller, selective, and ligand-
responsive systems26. Accordingly, the design of programmable 
DNA binder/host–guest scaffold for mimicking cooperative TF-
pair systems and especially their cell-based applications is highly 
attractive. 
To achieve this, we designed PIPs conjugated to a host–guest 
Cyd–Ada scaffold, i.e., Pip-HoGu. We first evaluated them in 
vitro using the DNA-binding sequences of the Tax/CREB hetero-
dimer, which functions by cooperative recruitment of p300 that is 
essential for HLTV-1 virus amplification27,28 Ada1 (PIP1-Ada) 
consists of a PIP moiety to target the Tax binding site (5′-
WWGGCW-3′) conjugated to Ada via a mini-PEG linker (Figure 
1)24. Host conjugate Cyd1 (PIP2-Cyd) contains a Cyd moiety and 
a CREB-competitive-binding PIP (5′-WGWCGW-3′). We gener-
ated series of positive- and negative-binding sequences, and the 
difference in binding originates from the relative positions of the 
Ada1 and Cyd1 binding sites (Figure 2A). In positive-binding 
sequences, Cyd–Ada covers only a short distance (equal to the 
gap distance) (Figure S1). In contrast, in the negative-binding 
mode, Ada must bridge two PIP-binding sites plus the gap dis-
tance, making it impossible for Ada to interact with Cyd. 
 
Figure 2. Tm assay illustrating the cooperativity of Pip-HoGu. (A) 
The DNA oligomers (ODNs) used in the Tm assay, including posi-
tive (ODN1′P–ODN6P) and negative (ODN1′N–ODN6N) bind-
ing sequences. The gap distance (green) is the number of bp be-
tween the binding sites of Ada1 (blue) and Cyd1 (red). The chart 
only shows the forward DNA strand. (B) Tm profiles of positive 
ODNs (TmP, light blue), negative ODNs (TmN, gray), positive 
ODNs/Ada1–Cyd1 (TmPA, blue), and negative ODNs/Ada1–
Cyd1 (TmNA, black). (C) ∆∆Tm profiles of cooperativity of Ada1–
Cyd1 assemblies. ∆Tm = Tm (ODNs/PIPs) – Tm (ODNs); ∆∆Tm = 
∆TmP – ∆TmN. Error bars indicate the standard deviation of three 
replicates. 
A thermal stabilization assay (Tm assay) was performed to 
evaluate the cooperative binding potency and how it was influ-
enced by the gap distance29. In the positive-binding mode, the 
overall thermal stability of Ada1–Cyd1 had a ∆TmP value of 9–15 
°C (∆TmP = TmP – Tm) in a gap-distance-dependent manner (Figure 
2B, Table S1). In negative-binding mode, however, there were no 
gap-distance-dependent effects on the thermal stability of Ada1–
Cyd1 with ∆TmN values around 9–10 °C (Table S1). In the control 
experiment with mixture of PIP1 and PIP2, there was no signifi-
cant difference of thermal stability between positive- and nega-
tive-binding sequences (Figure S2). Therefore, the discrepancy of 
thermal stabilization effect between positive- and negative-
binding modes should mainly attributable to the cooperative inter-
action of the Cyd–Ada complexes30,31. The results showed that 
positive-binding ODNs with 0–5 bp gap distances displayed co-
operative binding function, and no cooperative effect was ob-
served with gap distances ≥6 bp (Figure 2C). These results high-
light the gap-distance dependency of cooperative binding energies. 
ODN2P with a 2-bp gap distance demonstrated the highest level 
of cooperation (∆∆Tm = 7.2 °C). Of note, a 1-bp mismatch Tm 
assay showed that Pip-HoGu exhibited high sequence specificity 
with a ∆∆Tm of 8.3 °C (Table S2)32.  
 
Figure 3. EMSA illustrating the cooperativity of Pip-HoGu. (A) 
The gel-shift behavior of all the positive-binding sequences with 
Ada1–Cyd1. Concentrations are shown in figure. (B) Quantitative 
EMSA of ODN2P with Cyd1 at various concentrations (top) and 
Cyd1 supplemented with saturated Ada1 (bottom). ODNs con-
centration: 0.1 µM. (C) Equilibrium association constants and free 
energies for ODN2P with Ada1–Cyd1.  
Parallel to the Tm assay, electrophoretic mobility shift assays 
(EMSAs) were conducted to visualize band-shift behavior upon 
formation of stable complexes33. The band upshifts for Ada1, 
Cyd1, and Ada1–Cyd1 with ODN2P can be clearly distinguished 
(Figure S3). Next, fixed concentrations of Ada1–Cyd1 were al-
lowed to equilibrate with all ODNs. In agreement with the results 
of the Tm assay, the appearance of an upshifted band showed that 
ODNs with positive-binding mode and 0–5 bp gap distances dis-
play cooperative binding (Figure 3A). Ada1–Cyd1 shows sub-
stantially weaker band shift with ODN0P, for which steric hin-
drance might be partially responsible. In comparison, no com-
plexes were observed for DNA sequences of –1 bp and >6 bp. 
Moreover, no negative-binding mode DNA sequences could form 
upshifted band indicative of cooperative complexes, and there was 
also no upshifted band of negative ODNs with Ada1 or Cyd1 
individually, suggesting cooperative complex mediated sequence 
selectivity (Figure S4)3. In addition, competitive EMSA assays 
showed that cooperation was weakened in the presence of a guest 
competitor (Figure S5)34. 
Quantitative EMSAs were performed to analyze the magnitude 
of cooperativity and the equilibrium association constant was 
determined by fitting to the Langmuir binding isotherm35. The 
increase in the upshifted band for ODN2P at various concentra-
tions of Cyd1 alone and in the presence of Ada1 at excess con-
centration demonstrates the cooperative effect (Figure 3B)36. Spe-
cifically, the data generated an equilibrium association constant of 
2.50 × 105 M–1 (K1) for Cyd1 alone, and promisingly increased to 
1.25 × 107 M–1 (K1,2) in the presence of Ada1 (Figure 3C). Using 
the equation for the free energy of binding, the free energies of 
binding for Cyd1 alone and in the presence of Ada1 were –7.36 
and –9.68 kcal·mol–1, respectively, giving a minimum free energy 
of interaction (G2-1 – G2) of –2.32 kcal·mol–137. Therefore, Pip-
HoGu has superior cooperation-stabilization effects to the previ-
ously reported 8-bp DNA duplex (–2.2 kcal·mol–1) and the natural 
phage λ repressor system (–2.0 kcal·mol–1).37,38. Concomitantly, a 
surface plasmon resonance (SPR) assay was further validated 
quantitatively the cooperative effects of Pip-HoGu assembly 
(Table S3, Figure S7)39. 
  
Figure 4. Mechanistic studies of cooperative binding. (A) Gel-
shift behavior Ada2–Cyd1. (B) Tm profiles of all positive-binding 
sequences in the presence of Ada1–Cyd1 (TmPA, blue, same as 
Figure 2B) and Ada2–Cyd1 (TmPB, red).  
Continually, we studied the influence of linker length on coop-
erative binding since the underlying mechanisms of gap-distance-
dependent cooperativity (≤5 bp) are not totally clear19. For this, 
we used Ada2, which has a long, double mini-PEG linker (Figure 
1). In the EMSA and Tm assay, Ada2–Cyd1 showed similar coop-
erative patterns to Ada1–Cyd1, i.e., only those DNA sequences 
with gap distances of 0–5 bp could form cooperative complexes 
(Figure 4A, B). Specifically, Ada2–Cyd1 showed lower stability 
for gap distances of 0–4 bp in the Tm assay. This demonstrated 
that an extra-long linker might destabilize the binding affinity of 
the complex over short gap distances. Interestingly, when the gap 
distance was extended to 5–6 bp, Ada2–Cyd1 displayed slightly 
higher stability than Ada1–Cyd1 because the longer and more 
flexible linker can reduce the tension of complex formation. In 
conclusion, the cooperative energy of Pip-HoGu was highly dis-
tance dependent and that gap distances of >5 bp diminish the 
cooperation, even when the linker region was long enough to 
allow the encounter of host–guest moieties. This can be explained 
by the hydrophobic and van der Waals interactions of Cyd–
Ada16,40. 
 
Figure 5. Cell-based assay of Pip-HoGu. (A) Crystal structure of 
ERα homodimer and DNA sequence. (B) Schematic diagram of 
ERE-driven luciferase in T47DK-BLuc cells. (C) The structural 
design of Ada3 and Cyd2 targeting ERE sites (Figure S8). (D) 
Luciferase activity assay after normalization to the total protein 
concentration. 
Because we had compellingly demonstrated its cooperativity in 
several in vitro assay systems, we were encouraged to apply Pip-
HoGu to a cell-based assay. The estrogen response element (ERE) 
is the specific target motif of the estrogen receptor α (ERα) ho-
modimer, which induces significant downstream gene activation 
(Figure 5A)41. In ERα-positive, 17β-estradiol-stimulated T47D-
KBluc cells that highly express luciferase after binding of three 
tandem ERα TF pairs, Ada3, Cyd2, and Ada3–Cyd2 that bound 
to the ERE consensus half-site (5′-WGGWCW-3′) were tested for 
48 h together with the delivery reagent endoporter (Figure 5B, 
C)42. The effects of PIPs were measured by luciferase activity 
normalized to total protein concentration43,44. Monotreatment with 
Ada3 showed only moderate-to-weak inhibitory activity (IC50 ≥ 2 
µM) while very weak activity was observed for Cyd2 (<20% 
inhibition) (Figure 5D). When cells were treated with a combina-
tion of Ada3 and Cyd2, 4–5-fold enhancement of the inhibitory 
effect was observed, which strongly correlated with the coopera-
tive interactions of the host–guest system. The use of endoporter 
ensured that Ada3 and Cyd2 reached homodimer-binding sites at 
the same time, and it is plausible that Pip-HoGu could also work 
well for heterodimer binding sites in the absence of endoporter44. 
This cell-based assay system demonstrated for the first time that 
the individual host–guest interactions of Pip-HoGu could effec-
tively stabilize the PIP pair–DNA cooperative interaction and 
potently inhibit natural TF-pair binding in cells. 
Cooperation between TF pairs is ubiquitous in cells8. Our pro-
totype Pip-HoGu defines a general framework for mimicking 
cooperative TF pair–DNA interactions through the integration of 
programmable DNA binders and a host–guest system. In vitro 
assays showed that Ada1–Cyd1 assemblies formed stable cooper-
ative binding complexes with target DNA sequences with 0–5 bp 
gap distances. In essence, the cell-based assay demonstrated that 
our artificial Ada3–Cyd2 assemblies formed highly stable coop-
erative complexes that competed with naturally occurring cooper-
ative TF pair–DNA systems. Therefore, Pip-HoGu could be ap-
plied to the regulation of spatiotemporally variable gene expres-
sion patterns. 
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MATERIALS AND METHODS 
General 
The reagents for polyamide syntheses such as Fmoc-Py-OH, Fmoc-Im-OH, Fmoc-Py-Im-OH, and 
Im-CCl3, solid supports (Fmoc-Py-oxime resin and Fmoc-β Ala-Wang resin), 
O-(1H-6-chlorobenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HCTU) and 
benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) were from HiPep 
Laboratories (Kyoto, Japan). Trifluoroacetic acid (TFA), 3,3′-diamino-N-methyldipropylamine, 
N,N-diisopropylethylamine (DIEA), dichloromethane (DCM), methanol, acetic acid (AcOH), 
1-methyl-2-prrrolidone (NMP), and N,N-dimethylformamide (DMF) were obtained from Nacalai 
Tesque (Kyoto, Japan). Fmoc-D-Dab (Boc)-OH and Fmoc-NH-dPEG3-COOH were obtained from 
Iris Biotech GmbH (Marktredwitz, Deutschland). Polyamide-chain assembly was performed on an 
automated synthesizer, PSSM-8 (Shimadzu, Kyoto, Japan). HPLC grade acetonitrile (Nacalai 
tesque) was used for both analytical and preparative HPLC. Water was prepared by a Milli-Q 
apparatus (Millipore, Tokyo, Japan). All chemicals were used as received. Analyses by 
reversed-phase RP-HPLC were carried out online LCMS (Agilent 1100 ion-trap mass 
spectrometer, HCT ultra, Bruker Daltonics, Yokohama, Japan), with analytical RP-HPLC columns, 
UV spectra were measured on a NanoDrop 2000c (Thermo Fisher Scientific). 
Synthesis of Ts-β-CD.  
Weight out β-CD (7.0 g, 6.2 mmol) and 1-(p-toluenesulfonyl) imidazole (1.8 g, 8.0 mmol), and 
dissolved in 70 mL of water in a 200 ml conical flask containing a stir bar1. The suspension was 
stirred vigorously for 4 h at room temperature. Aqueous NaOH solution (20% wt/vol, 10 ml) was 
gradually added over 15 min. The mixture was stirred for an additional 10 min and filtered off the 
insoluble solid and collect the filtrate. Neutralize the filtrate to pH 7.0 with ammonium chloride 
(5.0 g, 0.1 mol) to induce precipitation. The precipitate was filtered off and washed with 3 × 10 
mL of cold water and 2 × 10 mL of acetone. The product was dried in vacuum. The pure 
6-O-monotosyl-β-CD (Ts-β-CD) was dried overnight in oil vacuum and obtained as white powder 
(2.8g, 35% yield). ESI-TOF-MS: m/z calcd for C49H77O37S+ [M+H]+: 1289.3824; found: 




Synthesis of β-CD-EDA 
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2.8 g of Ts-β-CD was reacted with excess amount of EDA (30 ml) at 75℃ for 4 h. After the 
reaction was completed, the mixture was allowed to cool to room temperature, and then put the 
solution in ice water2. Gradually added 30 ml of cold acetone and cooled down the solution to 0℃. 
The precipitate was repeatedly dissolved in 15 ml of water-methanol mixture, and poured into 30 
ml of acetone several times for the removal of unreacted EDA. The sample obtained was dried at 
vacuum for 24 h and pure β-CD-EDA was obtained as white powder (1.5 g, 59% yield). 
ESI-TOF-MS: m/z calcd for C44H77N2O34+ [M+H]+: 1177.4358; found: 1177.2965, 1178.3079.	 	
	
Synthesis of β-CD-AA-Bn 
To a 25 ml conical flask, there was sequentially added 52 mg 6-(benzyloxy)-6-oxohexanoic acid 
(AA-Bn), 20 mg PyBOP and 15 ml DMF. Then 13 ul DIEA was injected into the mixture and 
stirred for 15 min for carboxyl acid group activation at room temperature. Added 250 mg 
β-CD-EDA and stirred vigorously at room temperature for 1h. The precipitate was repeatedly 
dissolved in 15 ml of water-methanol mixture and poured into 30 ml of acetone several times. The 
sample obtained was dried at vacuum for 24 h and pure EDA-β-CD was obtained as white powder 
(187 mg, 63% yield). ESI-TOF-MS: m/z calcd for C57H91N2O37+ [M+H]+: 1395.5301; found: 
1395.5491, 1396.5601.	 	
	
Synthesis of β-CD-Adipic acid 
187 mg of β-CD-AA-Bn and 1.8 mg Pd/C were added to 15 ml methanol in 25 ml flask, then put 
it under hydrogen reduction system for 2 h. Removed Pd/C by double filtration and then pure into 
ether followed by AcOEt. Then white solid was obtained by centrifugation (174 mg, 99% yield). 




Polyamide Fmoc coupling procedure 
Polyamides were prepared using PSSM-8 peptide synthesizer (Shimadzu, Kyoto) with a 
computer-assisted operation system at 43 mg of Fmoc-Pyrrol-oxime resin and β Ala-Wang resin 
(ca. 0.42 mmol/g, 100~200 mesh) by Fmoc solid-phase chemistry3,4. Reaction cycles were as 
follows: deblocking step for 4 min x 2, 20% piperidine in DMF; coupling step for 60 min, 
corresponding carboxylic acids, HCTU (88 mg), diisopropylethylamine (DIEA) (36 µL), 
1-methyl-2-pyrrolidone (NMP); washing step for 1 min x 5, DMF. Each coupling reagents in steps 
were prepared in NMP solution of Fmoc-Py-COOH (77 mg), Fmoc-Im-COOH (77 mg), 
Fmoc-Py-Im-COOH (70 mg), Fmoc-β-COOH (66 mg), Fmoc-γ-COOH (69 mg) and Fmoc-mini 
PEG-COOH (69 mg). All other couplings were carried out with single-couple cycles with stirred 
by N2 gas bubbling. Typically, resin (40 mg) was swollen in 1 mL of NMP in a 2.5-mL plastic 
reaction vessel for 30 min. 2-mL plastic centrifuge tubes with loading Fmoc-monomers with 
HCTU in NMP 1 mL were placed in programmed position. All lines were washed with NMP after 
solution transfers. After the completion of the synthesis by the peptide synthesizer, the resin was 
washed with DMF (1 mL × 2), methanol (1 mL × 2), and dried in a desiccator at room temperature 
in vacuo.  
Resin cleavage and purification procedure 
The resulting polyamide-oxime resin was cleaved from the solid support with 
N,N-dimethyl-1,3-propyldiamine for 3 h at 45 °C. Polyamide-β Ala-Wang resin was cleaved from 
the solid support with 95% TFA, 2.5% triisopropylsilane, and 2.5% water for 30 min at room 
termperature. Resin was filtered off, and the resulting liquor was treated with diethyl ether. The 
precipitated crude polyamide was washed three times with diethyl ether and analyzed by 
RP-HPLC. Crude polyamides were purified on a preparative column at 40°C. The purified 
peptides were assessed by the LC-MS system. 
Synthesis of Ada1 
Polyamide synthetic procedure has been described above. The condition of Boc- deprotection is 
20% TFA in DCM, 30 min at room temperature. The resin was washed by DMF, DCM, and dried 
in vacuum. Then Fmoc chemistry was conducted for the coupling of mini-PEG linker. After 
deprotection of Fmoc group, 1-Adamantaneacetic acid (40 mg) was coupled by Fmoc method. 
The resin cleavage and compound purification procedure have been described above. Ada1 was 
obtained as a white powder. MALDI-TOF MS: m/z calcd for C74H97N24O14+ [M+H]+: 1545.7616; 
found: 1545.107.. HPLC: tR=12.667 min (0.1 % TFA/MeCN, linear gradient 0–100 %, 0–20 




Synthesis of Ada2 
The synthetic procedure was same as Ada1, except double coupling step of mini-PEG linker. 
Ada2 was obtained as a white powder. ESI-TOF MS: m/z calcd for C80H110N25O173+ [M+3H]3+: 
564.2837; found: 564.2218, 564.5593, 564.9067; C80H109N25O172+ [M+2H]2+: 845.9216; found: 
845.8101, 846.3149, 846.8141. HPLC: tR=12.775 min (0.1 % TFA/MeCN, linear gradient 0–
100 %, 0–20 min). (Mass data was attached in the bottom) 
Synthesis of Ada3 
Ada3 was obtained as a white powder. MALDI-TOF MS: m/z calcd for C80H105N26NaO16 
[M+Na]+: 1709.876; found: 1709.975. HPLC: tR=20.325 min (0.1 % TFA/MeCN, linear 
gradient 0–100 %, 0–40 min). 
	
Synthesis of CyD1  
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Polyamide synthetic procedures have been described above. The coupling condition of linker is 
adipic acid (12.5 mg), HCTU (74 mg), DIEA (22 µL), NMP (1000 µL), 60 min. Then washed by 
DMF, DCM, and dried in vacuum. The resin was activated by PyBOP for 30min, then EDA-β-CD 
conjugated to the polyamides and stirred for 2 h, and washed by above mentioned solvent. The 
resulting polyamide-resin was cleaved from the solid support with 
N,N-dimethyl-1,3-propyldiamine for 3 h at 45 °C. Resin was filtered off, and the resulting liquor 
was treated with DCM. The precipitated crude polyamide was washed three times with DCM and 
analyzed by RP-HPLC. Crude polyamides were purified on a preparative column, HiPep-Intrada, 
at 40 °C. The purified peptides were assessed by the LC-MS system. CyD1 was obtained as a 
white powder. ESI-TOF MS: m/z calcd for C110H163N25O484+ [M+4H]4+: 650.7779; found: 
650.4527, 650.7227; C110H162N25O483+ [M+3H]3+: 867.3679; found: 866.9463, 867.2734, 
867.6157. HPLC: tR=9.500 min (0.1 % TFA/MeCN, linear gradient 0–100 %, 0–20 min). 
(Mass data was attached in the bottom)	 	
 
Synthesis of Cyd2 
Cyd2 was obtained as a white powder. MALDI-TOF MS: m/z calcd for C116H168N27NaO50+ 
[M+Na]+: 2763.1404; found: 2764.437. HPLC: tR=14.775 min (0.1 % TFA/MeCN, linear 





Synthesis of PIP1 
PIP1 was obtained as a white powder. ESI-TOF MS: m/z calcd for C61H78N23O12+ [M+H]+: 
1324.6195; found: 1324.3297, 1325.3289; C61H78N23O122+ [M+2H]2+ found: 662.6921, 663.1908. 
HPLC: tR=11.675 min (0.1 % TFA/MeCN, linear gradient 0–100 %, 0–20 min). (Mass data 
was attached in the bottom) 
	
Synthesis of PIP2 
PIP2 was obtained as a white powder. MALDI-TOF MS: m/z calcd for C62H80N23O13+ [M+H]+: 
1354.6300; found: 1353.893; C61H78N23O12+ [M+Na]+ found: 1375.911. HPLC: tR=11.208 min 





Thermal Denaturation Analyses 
Thermal denaturation analyses of the polyamide–DNA complex were performed on a V-650 
spectrophotometer (JASCO) having a cell path length of 1 cm equipped with a thermocontrolled 
PAC-743R cell changer (JASCO) and a refrigerated and heated circulator F25-ED (Julabo) as 
described3. The sequences of the DNAs used were purchased from Sigma-Aldrich. The analysis 
buffer is as follows: the aqueous solution of 10 mM sodium chloride and 10 mM sodium 
cacodylate at pH 7.0 containing 0.25% v/v DMSO. The final concentrations of polyamides and 
dsDNA were 7.5 µM and 2.5 µM, respectively (3:1 stoichiometry). Denaturation profiles were 
recorded at λ = 260 nm from 25 to 95 °C at a rate of 1.0 °C/min, and melting temperatures were 
measured as the maximum of the first derivative of the profiles. Reported values were the 
averages of at least three measurements. 
Electrophoretic mobility shift assay (EMSA) 
Preparation loading mixture5.  The sequences of the DNAs used were purchased from 
Sigma-Aldrich. The analysis buffer is as follows: the aqueous solution of 10 mM sodium chloride 
and 10 mM sodium cacodylate at pH 7.0 containing 0.25% v/v DMSO. The final concentrations of 
polyamides and dsDNA were clarified in the manuscript. Gel Loading Dye, Purple (6X no SDS 
B7025S, New England Biolab). 
Preparation of gels. In a clean glass beaker the following reagents were mixture in the given 
order (10 ml system, reagent volume doubled for 20 ml system). 5.25 mL MiliQ, 1 mL 10× TBE, 
and 3.75 mL of 40% Acrylamide/Bis Solution (29 : 1), followed by gas-removing to ensure the 
removal of all air bubbles. Then 90 µL APS (10% w/w in MiliQ) and 100 µL TEMED (10% v/v in 
MiliQ) were then added to the mixture and mixed properly before pouring it gently along parallel 
glass plates. Sufficient time was given for polymerization (20 min). 
Electrophoresis. A pre-run of the gels was performed prior to loading. Care was taken to see that 
the gel were properly immersed in 1× Tris-Borate-EDTA buffer (TBE buffer) and the loading 
wells were free from any air bubbles. The wells were washed after the pre-run. Instrument settings: 
120 V for 30 min at 4°C. 4 µL of the loading mixture was then loaded onto the wells. Pre-run 
again at 120 V for 30 minutes at 4°C. Then gel running as the instrument settings: 180 V for 160 
min at 4°C. 
Analysis of gels. The bands were stained with SYBR gold (10000× concentration in DMSO, from 
Thermofisher) and quantified with a FujiFilm FLA-3000G fluorescent imaging analyzer. 
SPR Binding Assays 
The SPR assays were performed using a BIACORE X instrument as previously described6. 
Biotinylated hairpin DNA purchased from JBioS, whose sequence was 
5′-biotin-AACTTAGGCTAATGACGTATATGTTTTCATATACGTCATTAGCCTAAGTT-3′, 
was immobilized on streptavidin-coated sensor chip SA to obtain the desired immobilization level 
(approximately 1100 RU rise). The assays were carried out using HBS-EP (10 mM HEPES (pH 
7.4), 150 mM NaCl, 3 mM EDTA, 0.005% v/v Surfactant P20), purchased from GE Healthcare, 
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with 0.1% DMSO at 25 °C. A series of sample solutions with various concentrations were 
prepared in the buffer with 0.1% DMSO and injected at a flow rate of 20 mL/min. To calculate the 
association rate (ka), dissociation rate (kd), and dissociation constant (KD), data processing was 
performed with 1:1 binding with mass a transfer model using BIA evaluation 4.1 program.  
Cell culture and Cell treatment 
T47D-KBluc cell line used was purchased directly from American Type Culture Collection 
(ATCC) and no subsequent authentications were done by the authors7. Cells were grown in 
RPMI-1640 (Gibco) held at 37oC in 5% CO2. Media was supplemented with 10% FBS (Sigma, 
unheated) and 1% penicillin/streptamycin. Before one week of compound treatment, media was 
supplemented with 10% FBS (Sigma, unheated) without penicillin/streptomycin.  
T47D-KBluc cells were plated at 2×105 cells per well in 24-well plates, incubated in phenol 
red-free RPMI 1640 medium growth media (Gibco) containing 10 nmol/L E2 supplemented with 
10% hycloneTM FBS (GE healthcare, unheated)8. After 24 hours, plates were replenished with 
same medium dosed with 0.1-2 µmol/L polyamides and then add 3 µl Endoporter (Gene Tools) to 
the concentration of 6 µmol/L. The cells were then incubated for 48 hours9. 
BCA protein assay and luciferase assay 
Cell lyses were obtained with 80 µl/well luciferase cell culture lysis reagent (Promega). Then cell 
lyses were analyzed using both PierceTM BCA protein assay (Thermo) and luciferase assay system 
(Promega) according to the manufacturers’ instructions. Luciferase assay data were normalized 
with BCA protein assay10. 
Statistical analysis 
Results for continuous variables were presented as the mean ± standard error. Two-group 
differences in continuous variables were assessed by the unpaired t-test. Statistical analysis was 
performed by comparing treated samples with untreated controls. The statistical analyses were 
performed using GraphPad Prism 5. 
Computational experiments 
Software BIOVIA Discovery Studio version 17.1 from Accelrys was used for this purpose11. The 
primary geometric PIP structure, β-CD, and adamantine were taken from the crystal structure 
3OMJ12, 4D5B13, and 1LWL14 respectively. The starting structures of DNA, Ada1, and Cyd1 
were modified and energy minimized using the tools in the software. After energy minimization 
without any constrains, the distance of hydrogen bond between PIPs and DNA are ranging from 
1.928 to 3.328 Å. The following table list one example of Distance Monitoring data (2 bp gap 
distance, Figure S1): 
Name     Visible Color    Parent       X       Y       Z   Distance 
Distance4 0 Yes 0 255 0 <TreeRoot> -3.76078 7.09167 -5.21038 2.314 
Distance5 0 Yes 0 255 0 <TreeRoot> -3.18661 9.64179 -8.72648 2.642 
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Distance6 0 Yes 0 255 0 <TreeRoot> -0.939881 11.5555 -12.3476 2.047 
Distance7 0 Yes 0 255 0 <TreeRoot> -0.298467 11.8243 -14.8366 2.821 
Distance8 0 Yes 0 255 0 <TreeRoot> 1.87322 10.884 -15.7153 2.814 
Distance9 0 Yes 0 255 0 <TreeRoot> 3.47262 9.02065 -19.3201 1.928 
Distance11 Yes 0 255 0 <TreeRoot> 1.16246 10.2712 -22.2429 2.014 
Distance12 Yes 0 255 0 <TreeRoot> 0.801845 11.1992 -20.2019 2.578 
Distance13 Yes 0 255 0 <TreeRoot> -1.45549 10.4291 -19.2067 3.078 
Distance14 Yes 0 255 0 <TreeRoot> -3.37622 9.14564 -15.4857 2.652 
Distance15 Yes 0 255 0 <TreeRoot> -4.34768 6.72967 -11.6213 3.058 
Distance16 Yes 0 255 0 <TreeRoot> -4.9555 6.03272 -9.09647 3.328 
Distance17 Yes 0 255 0 <TreeRoot> -3.36976 4.24082 -8.41492 3.304 
Distance18 Yes 0 255 0 <TreeRoot> -1.66559 10.2419 22.9747 3.079 
Distance19 Yes 0 255 0 <TreeRoot> 0.625469 11.132 18.967 3.301 
Distance20 Yes 0 255 0 <TreeRoot> 3.37375 10.2939 15.622 2.531 
Distance21 Yes 0 255 0 <TreeRoot> 4.31715 7.83195 12.1853 2.673 
Distance22 Yes 0 255 0 <TreeRoot> 3.79255 5.27068 8.63684 2.704 
Distance23 Yes 0 255 0 <TreeRoot> 5.12323 7.09738 9.85063 2.645 
Distance24 Yes 0 255 0 <TreeRoot> 3.02919 10.7066 9.23694 2.29 
Distance25 Yes 0 255 0 <TreeRoot> 2.70262 11.6067 11.6097 2.641 
Distance26 Yes 0 255 0 <TreeRoot> 0.251417 11.73 12.1004 2.751 
Distance27 Yes 0 255 0 <TreeRoot> -0.151984 12.2931 15.0042 2.869 
Distance28 Yes 0 255 0 <TreeRoot> -1.99701 10.8087 15.4324 2.667 




SUPPORTING TABLES AND FIGURES 
Table S1. Results of Tm assay 
 
*∆Tm = Tm (ODNs/PIPs) - Tm (ODNs); ∆∆Tm = ∆TmP - ∆TmN. Error bars are ranging from 0.25-0.7 °C 






Table S2. Results of Tm assay of mismatch sequence 
 
ODN2P:  5'-AACTTAGGCTAATGACGTATAT-3'  
ODN2PM: 5'-AACTTAGGCTAATGATGTATAT-3'  
a∆Tm = Tm (ODNs/PIPs) - Tm (ODNs); ∆∆Tm = ∆TmP - ∆TmPM. Error bars are ranging from 0.2-0.65 °C 
indicating standard deviations of three replicates. 
  
ODNs Tm [℃] TmPA [℃] ∆TmA [℃]
a
 ∆∆Tm [℃]  
ODN2P 45.8 63.2 17.4 
8.4 
  








5 bp gap distance 
(Simplified model structure) 
6 bp gap distance 
(Simplified model structure) 
2 bp gap distance 
(Retaining structural constrain and 




Figure S2. Results of Tm assay of PIP1–PIP2 
 
(A) Chemical structures of PIP1 and PIP2; (B) Tm profiles of positive ODNs (TmP, light blue line), negative ODNs 
(TmN, gray line), positive ODNs/PIP1–PIP2 (TmPC, brown line), and negative ODNs/ PIP1–PIP2 (TmNC, green line). 
*Error bars are ranging from 0.25-0.7 °C indicating standard deviations of three replicates.  
ODN8P: 5'-AATTAGGCTGGAATTCCTGACGTATA-3';  
ODN8N: 5'-AATTGACGTGGAATTCCTAGGCTATA-3'.  
Here only show forward DNA strands with complimentary DNA strands omitted. 
	
At the gap distance of –1 bp in positive- and negative-binding sequences, the Tm value 
was far lower than others, which were in consistent with spatial incompatibility upon 
two PIPs binding. The huge increase of Tm value at the gap distance of 8 bp can be 
explained by the insertion of multiple G/C in the gap region. One thing should be 
noticed here that, the conjugation of host-guest moieties in PIPs impair its binding 
affinity to the target DNA sequences to a reasonable extent, which could be observed 
by comparing TmNA (Negative-ODNs/Ada1–Cyd1) and TmNC (Negative-ODNs/PP1–
PP2). Therefore, in the control experiment with mixture of PIP1 and PIP2, there was 
no significant difference of thermal stability between positive- and negative-binding 











*Discrimination of up-shifted band of ODN2P with Ada1 (green arrow), Cyd1 (purple arrow), and Ada1/Cyd1 




Figure S4. Up-shifted band of ODN2P of positive binding mode and ODN2N of 






Figure S5. Competitive assay of Ada1/Cyd1/ODN2P with Phenyladamantane in 
EMSA. 
	  
*ODN2P concentration: 1 µM. Ada1/Cyd1 concentration: 3 µM. Ph-ada concentration is from 1 µM, 5 µM, 10 





Figure S6. Job plot of Ada1/Cyd1/ODN2P in EMSA. 
	  
*The total concentration of conjugates was constant at 1× 10-6 M by preparing a total of 12 µL mixture of solutions.. 
∆F is the percentage of band shift in fluorescence intensity normalized to lane 4. X is the mole fraction of Ada1 to 
Cyd1. The highest band shift point at 0.5 fraction of [Ada1]/[Ada1]+[Cyd1] indicates that the stoichiometry of 




Figure S7. SPR binding assays conducted to evaluate the binding properties of 
Ada1 and Cyd1.  
   
   
*SPR sensorgrams for interactions of Ada1 (A), Ada1 + fixed concentration of Cyd1 (B), Cyd1 (C), and Cyd1 
+fixed concentration of Ada1. The concentrations were showed in figure. Extensive concentration of Ada1 and 
Cyd1 were dissolved in HBS-EP buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, and 0.005 % 
surfactant P20) with 0.1% DMSO. These solutions were passed over a 5’-biotinylated DNA hairpin, which contain 
the binding sites of Ada1 and Cyd1, immobilized on a sensor chip through a biotin-avidin system. Under these 
conditions, the binding affinities were evaluated and by applying 1:1 binding model with mass transfer to each 
sensorgram, the association rate constant ka, dissociation rate constant kd, and disassociation equilibrium constant 
KD could be determined. Kinetic constants were calculated from the surface plasmon resonance sensorgrams for 
the interaction of polyamide with the DNA immobilized on the surface of a sensor chip SA (Biacore assays). KD, 












β-CD-AA-Bn. was obtained as white powder. ESI-TOF-MS: m/z calcd for C57H91N2O37+ [M+H]+: 
1395.5301; found: 1395.5491, 1396.5601.	  
 
β-CD-Adipic acid was obtained as white powder. ESI-TOF-MS: m/z calcd for C50H85N2O37+ 




Ada1 was obtained as a white powder. MALDI-TOF MS: m/z calcd for C74H97N24O14+ [M+H]+: 
1545.7616; found: 1545.107. HPLC: tR=12.67 min (0.1 % TFA/MeCN, linear gradient 0–
100 %, 0–20 min). 
 
Ada2 was obtained as a white powder. ESI-TOF MS: m/z calcd for C80H110N25O173+ [M+3H]3+: 
564.2837; found: 564.2218, 564.5593, 564.9067; C80H109N25O172+ [M+2H]2+: 845.9216; found: 
845.8101, 846.3149, 846.8141. HPLC: tR=12.78 min (0.1 % TFA/MeCN, linear gradient 0–






Ada3 was obtained as a white powder. MALDI-TOF MS: m/z calcd for C80H105N26NaO16 
[M+Na]+: 1709.876; found: 1709.975. HPLC: tR=20.325 min (0.1 % TFA/MeCN, linear 
gradient 0–100 %, 0–40 min). 
 
 
CyD1 was obtained as a white powder. ESI-TOF MS: m/z calcd for C110H163N25O484+ [M+4H]4+: 
650.7779; found: 650.4527, 650.7227; C110H162N25O483+ [M+3H]3+: 867.3679; found: 866.9463, 






Cyd2 was obtained as a white powder. MALDI-TOF MS: m/z calcd for C116H168N27NaO50+ 
[M+Na]+: 2763.749; found: 2764.437. HPLC: tR=14.775 min (0.1 % TFA/MeCN, linear 
gradient 0–100 %, 0–40 min). 
 
 
PIP1 was obtained as a white powder. ESI-TOF MS: m/z calcd for C61H78N23O12+ [M+H]+: 
1324.6195; found: 1324.3297, 1325.3289; C61H78N23O122+ [M+2H]2+ found: 662.6921, 663.1908. 
HPLC: tR=11.675 min (0.1 % TFA/MeCN, linear gradient 0–100 %, 0–20 min). (Mass data 







PIP2 was obtained as a white powder. MALDI-TOF MS: m/z calcd for C62H80N23O13+ [M+H]+: 
1354.6300; found: 1353.893; C61H78N23O122+ [M+Na]+ found: 1375.911. HPLC: tR=11.208 min 
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